Martingale Asset Management L P Bridge Bio Pharma, Inc. Transaction History

Martingale Asset Management L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$13.29 - $18.01 $320,315 - $434,077	-24,102 Reduced 58.83%	16,870 $290,000
Q1 2023 May 12, 2023	SELL	$7.17 - $18.55 $3,606 - $9,330	-503 Reduced 1.21%	40,972 $679,000
Q4 2022 Feb 13, 2023	BUY	$6.74 - $11.52 $674 - $1,152	100 Added 0.24%	41,475 $316,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $13,450 - $20,937	1,694 Added 4.27%	41,375 $412,000
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $76,066 - $177,244	14,600 Added 58.21%	39,681 $360,000
Q1 2022 May 12, 2022	BUY	$7.34 - $17.16 $184,094 - $430,389	25,081 New	25,081 $254,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.